Entity Common Stock, Shares Outstanding of NAVIDEA BIOPHARMACEUTICALS, INC. from 01 Aug 2011 to 10 Nov 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 10 Nov 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 10 Nov 2023 was 100,084,385, a 209% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 100,084,385 +67,720,023 +209% 10 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 99,830,635 +69,463,343 +229% 09 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 32,851,252 +2,552,198 +8.4% 17 Mar 2023 10-K 27 Mar 2023 2022 FY
Q3 2022 32,364,362 +2,175,871 +7.2% 07 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 30,367,292 +204,047 +0.68% 08 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 30,299,054 +1,731,756 +6.1% 18 Mar 2022 10-K 28 Mar 2022 2021 FY
Q3 2021 30,188,491 +3,501,293 +13% 05 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 30,163,245 +4,317,273 +17% 06 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 28,567,298 +8,127,757 +40% 15 Mar 2021 10-K 26 Mar 2021 2020 FY
Q3 2020 26,687,198 +8,607,792 +48% 06 Nov 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 25,845,972 +7,786,566 +43% 07 Aug 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 20,439,541 -180,251,159 -90% 02 Mar 2020 10-K 18 Mar 2020 2019 FY
Q3 2019 18,079,406 -163,811,294 -90% 01 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 18,059,406 -145,560,684 -89% 01 Aug 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 200,690,700 +37,906,721 +23% 01 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 181,890,700 +19,634,054 +12% 01 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 163,620,090 +1,413,444 +0.87% 01 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 162,783,979 +885,641 +0.55% 01 Mar 2018 10-K 15 Mar 2018 2017 FY
Q3 2017 162,256,646 +6,493,917 +4.2% 01 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 162,206,646 +6,455,330 +4.1% 01 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 161,898,338 +6,331,755 +4.1% 01 Mar 2017 8-K 15 Dec 2017 2016 FY
Q3 2016 155,762,729 +63,064 +0.04% 01 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 155,751,316 +5,051,635 +3.4% 29 Jul 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 155,566,583 +5,229,485 +3.5% 01 Mar 2016 10-K 23 Mar 2016 2015 FY
Q3 2015 155,699,665 +4,959,184 +3.3% 02 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 150,699,681 +63,788 +0.04% 31 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 150,337,098 +634,555 +0.42% 02 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 150,740,481 +16,394,998 +12% 31 Oct 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 150,635,893 +29,161,434 +24% 01 Aug 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 149,702,543 +32,091,577 +27% 28 Feb 2014 10-K 14 Mar 2014 2013 FY
Q3 2013 134,345,483 +26,954,851 +25% 05 Nov 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 121,474,459 +17,979,077 +17% 02 Aug 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 117,610,966 +21,108,636 +22% 01 Mar 2013 10-K/A 21 Mar 2013 2012 FY
Q3 2012 107,390,632 +12,280,105 +13% 02 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 103,495,382 +8,793,446 +9.3% 01 Aug 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 96,502,330 04 May 2012 10-Q 10 May 2012 2012 Q1
Q3 2011 95,110,527 01 Nov 2011 10-Q 09 Nov 2011 2011 Q3
Q2 2011 94,701,936 01 Aug 2011 10-Q 08 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.